BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11979448)

  • 21. Germline mutations of the RET proto-oncogene in eight Japanese patients with multiple endocrine neoplasia type 2A (MEN2A).
    Takiguchi-Shirahama S; Koyama K; Miyauchi A; Wakasugi T; Oishi S; Takami H; Hikiji K; Nakamura Y
    Hum Genet; 1995 Feb; 95(2):187-90. PubMed ID: 7860065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of gene expression induced by RET with MEN2A or MEN2B mutation.
    Watanabe T; Ichihara M; Hashimoto M; Shimono K; Shimoyama Y; Nagasaka T; Murakumo Y; Murakami H; Sugiura H; Iwata H; Ishiguro N; Takahashi M
    Am J Pathol; 2002 Jul; 161(1):249-56. PubMed ID: 12107109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Germline mutations in glial cell line-derived neurotrophic factor (GDNF) and RET in a Hirschsprung disease patient.
    Angrist M; Bolk S; Halushka M; Lapchak PA; Chakravarti A
    Nat Genet; 1996 Nov; 14(3):341-4. PubMed ID: 8896568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.
    Neumann HP; Eng C; Mulligan LM; Glavac D; Zäuner I; Ponder BA; Crossey PA; Maher ER; Brauch H
    JAMA; 1995 Oct; 274(14):1149-51. PubMed ID: 7563486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RET proto-oncogene: role in kidney development and molecular pathology.
    Salomon R; Attie T; Amiel J; Pelet A; Niaudet P; Lyonnet S
    Adv Nephrol Necker Hosp; 1998; 28():401-17. PubMed ID: 9890001
    [No Abstract]   [Full Text] [Related]  

  • 26. [Molecular diagnosis of multiple type 2 endocrine neoplasia].
    Amosenko FA; Pushkash K; Frilling A; Kozlova VN; Liubchenko LN; Kazubskaia TP; Brelysh KE; Gar'kavtseva RF; Kalinin VN
    Vestn Ross Akad Med Nauk; 2001; (2):34-7. PubMed ID: 11338505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RET oligonucleotide microarray for the detection of RET mutations in multiple endocrine neoplasia type 2 syndromes.
    Kim IJ; Kang HC; Park JH; Ku JL; Lee JS; Kwon HJ; Yoon KA; Heo SC; Yang HY; Cho BY; Kim SY; Oh SK; Youn YK; Park DJ; Lee MS; Lee KW; Park JG
    Clin Cancer Res; 2002 Feb; 8(2):457-63. PubMed ID: 11839664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cys 634 mutations in the RET proto-oncogene in Spanish families affected by MEN 2A.
    Sánchez B; Antiñolo G; Navarro E; Japón MA; Conde AF; Astorga R; Borrego S
    Hum Mutat; 1998; Suppl 1():S72-3. PubMed ID: 9452046
    [No Abstract]   [Full Text] [Related]  

  • 29. Mutation and deletion analysis of GFR alpha-1, encoding the co-receptor for the GDNF/RET complex, in human brain tumours.
    Gimm O; Gössling A; Marsh DJ; Dahia PL; Mulligan LM; von Deimling A; Eng C
    Br J Cancer; 1999 May; 80(3-4):383-6. PubMed ID: 10408842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RET proto-oncogene mutations are restricted to codon 618 in Cypriot families with multiple endocrine neoplasia 2.
    Neocleous V; Skordis N; Portides G; Efstathiou E; Costi C; Ioannou N; Pantzaris M; Anastasiadou V; Deltas C; Phylactou LA
    J Endocrinol Invest; 2011 Nov; 34(10):764-9. PubMed ID: 21422799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RET proto-oncogene mutations in French MEN 2A and FMTC families.
    Schuffenecker I; Billaud M; Calender A; Chambe B; Ginet N; Calmettes C; Modigliani E; Lenoir GM
    Hum Mol Genet; 1994 Nov; 3(11):1939-43. PubMed ID: 7874109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutational analysis of the GDNF/RET-GDNFR alpha signaling complex in a kindred with vesicoureteral reflux.
    Shefelbine SE; Khorana S; Schultz PN; Huang E; Thobe N; Hu ZJ; Fox GM; Jing S; Cote GJ; Gagel RF
    Hum Genet; 1998 Apr; 102(4):474-8. PubMed ID: 9600247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutational analysis of RET/GDNF/NTN genes in children with total colonic aganglionosis with small bowel involvement.
    Inoue K; Shimotake T; Iwai N
    Am J Med Genet; 2000 Aug; 93(4):278-84. PubMed ID: 10946353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RET and GDNF gene scanning in Hirschsprung patients using two dual denaturing gel systems.
    Hofstra RM; Wu Y; Stulp RP; Elfferich P; Osinga J; Maas SM; Siderius L; Brooks AS; vd Ende JJ; Heydendael VM; Severijnen RS; Bax KM; Meijers C; Buys CH
    Hum Mutat; 2000; 15(5):418-29. PubMed ID: 10790203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germline mutations of the RET ligand GDNF are not sufficient to cause Hirschsprung disease.
    Salomon R; Attié T; Pelet A; Bidaud C; Eng C; Amiel J; Sarnacki S; Goulet O; Ricour C; Nihoul-Fékété C; Munnich A; Lyonnet S
    Nat Genet; 1996 Nov; 14(3):345-7. PubMed ID: 8896569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
    Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
    Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic analysis of seven Mediterranean families with multiple endocrine neoplasia type 2A.
    Oriola J; Hernandez C; Simo R; Barcelo A; Casamitjana R; Vilardell E; Rivera-Fillat F
    Clin Endocrinol (Oxf); 1996 Feb; 44(2):207-12. PubMed ID: 8849576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of SNT/FRS2 docking site on RET receptor tyrosine kinase and its role for signal transduction.
    Kurokawa K; Iwashita T; Murakami H; Hayashi H; Kawai K; Takahashi M
    Oncogene; 2001 Apr; 20(16):1929-38. PubMed ID: 11360177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RET activation by germline MEN2A and MEN2B mutations.
    Borrello MG; Smith DP; Pasini B; Bongarzone I; Greco A; Lorenzo MJ; Arighi E; Miranda C; Eng C; Alberti L
    Oncogene; 1995 Dec; 11(11):2419-27. PubMed ID: 8570194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RET-familial medullary thyroid carcinoma mutants Y791F and S891A activate a Src/JAK/STAT3 pathway, independent of glial cell line-derived neurotrophic factor.
    Plaza Menacho I; Koster R; van der Sloot AM; Quax WJ; Osinga J; van der Sluis T; Hollema H; Burzynski GM; Gimm O; Buys CH; Eggen BJ; Hofstra RM
    Cancer Res; 2005 Mar; 65(5):1729-37. PubMed ID: 15753368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.